
|Articles|May 28, 2017
Kevzara Approval for RA Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
4
Bringing Bispecific Therapy Into the Outpatient Community Oncology Setting
5






































































































